RecruitingNot Applicable

Provocation After Nurse-Directed Assessment (PANDA) Study

Hong Kong440 participantsStarted 2025-09-01

Plain-language summary

The study aims to evaluate the effectiveness and safety of a collaborative nurse-allergist approach in penicillin allergy delabeling services. It also seeks to assess the impact on patients' quality of life and compare resource utilization and cost-effectiveness between the nurse-allergist collaborative approach and the traditional allergist-led approach.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Receiving inpatient or outpatient treatment at a participating hospital during the study period; * Possessing a documented penicillin allergy label; * Underwent penicillin allergy evaluation by the nurse-allergist collaborative approach or the traditional allergist-led approach * Demographic and clinical data required for the study available. Exclusion Criteria: * Patients unable to provide a complete medication history or history of penicillin allergy; * Patients with only emergency or short-term treatment records; * Patients who have taken steroids, antihistamines, or similar medications within the last 3 days.

What they're measuring

Delabelling Success Rate

Timeframe: 6 months

Trial details

NCT IDNCT07127835

SponsorThe University of Hong Kong

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-08-31

Contact for this trial

Elaine Lee

852 9440 3349 le446@hku.hk

View on ClinicalTrials.gov More Drug Allergy trials